Ophthalmology

Top Story

Robert E. Grant transitions from CEO to board vice chairman of Alphaeon

May 26, 2016

Robert E. Grant, founder of Alphaeon, will transition from his role as CEO to the role of vice chairman of the company’s board of directors, according to an Alphaeon press release.

The transition is expected to be completed by June 30.

Meeting News CoverageVideo

VIDEO: Wavefront-guided topography, accelerated cross-linking provides positive visual outcomes for irregular astigmatism

May 26, 2016
NEW ORLEANS — At the American Society of Cataract and Refractive Surgery meeting, Gustavo E. Tamayo, MD, discusses positive visual outcomes with the combination…
VideoFrom OSN Europe

VIDEO: Scleral spacing procedure increases patient satisfaction at 3 years

May 26, 2016
MILAN — At OSN Italy, Karl G. Stonecipher, MD, discusses 3-year results of a survey assessing patient satisfaction with the scleral spacing procedure and other options…
Meeting News Coverage

OCT angiography quantitates differences in lesion responses to anti-VEGF therapy

May 25, 2016
COLORADO SPRINGS, Colo. — Type 1 neovascular lesions are large, mature and resistant to anti-VEGF therapy, whereas type 3 lesions are small capillary tufts that…
Meeting News CoverageFrom OSN Europe

Progressive IOL for mini incision shows good preliminary study results

May 25, 2016
MILAN — A new progressive IOL for a mini incision provides optimal vision at all distances, with no halos and a minimal amount of glare, according to the…
More News Headlines »
Clinical Science

Focal Nonperfusion of Deep Retinal Capillary Plexus in Eyes With Epiretinal Membranes Revealed by Optical Coherence Tomography Angiography

Ophthalmic Surgery, Lasers and Imaging Retina, May 2016, Volume 47 Issue 5
To evaluate the leakage pattern in eyes with idiopathic epiretinal membranes (ERM) using fluorescein angiography (FA)…
More »
CME

Comparative Treatment Trials for Wet AMD: A Comprehensive Review

This activity is supported by educational grants from Allergan, Inc.; Genentech, Inc.; and Regeneron Pharmaceuticals, Inc.

The advent of intravitreal therapies to treat retinal diseases has revolutionized the management of retinal pathology…
More »
Featured
Highlights from ASCRS

Highlights from ASCRS

Video
Meeting News Coverage

VIDEO: Surgeon presents phase 3 clinical trial results of Rhopressa

May 24, 2016
More »